| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Laura Piddock | Q20203247 |
| P2093 | author name string | Simon Gibbons | |
| Michael Stavri | |||
| P2860 | cites work | Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance | Q24548472 |
| Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli | Q24613078 | ||
| Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor | Q24650801 | ||
| Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans | Q28344597 | ||
| Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance | Q30667520 | ||
| Discovery and biological evaluation of a new family of potent modulators of multidrug resistance: reversal of multidrug resistance of mouse lymphoma cells by new natural jatrophane diterpenoids isolated from Euphorbia species | Q30695267 | ||
| Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships | Q31917006 | ||
| The threat of vancomycin resistance | Q33646840 | ||
| Aminoglycoside-modifying enzymes | Q33745231 | ||
| Vancomycin-resistant enterococci | Q33975592 | ||
| Mechanisms of action and resistance of older and newer fluoroquinolones | Q34030757 | ||
| Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium | Q34047473 | ||
| The emergence and evolution of methicillin-resistant Staphylococcus aureus | Q34094813 | ||
| Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. | Q34143579 | ||
| Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus | Q34352260 | ||
| Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures | Q34384045 | ||
| Mechanisms of bacterial biocide and antibiotic resistance | Q34631438 | ||
| Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria | Q34647294 | ||
| Inducible NorA-mediated multidrug resistance in Staphylococcus aureus | Q35120701 | ||
| Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus | Q35814875 | ||
| Update on acquired tetracycline resistance genes | Q36101214 | ||
| Efflux-mediated antimicrobial resistance | Q36138147 | ||
| Role of mycobacterial efflux transporters in drug resistance: an unresolved question | Q36378353 | ||
| The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR). | Q36536579 | ||
| Multidrug-resistance efflux pumps - not just for resistance | Q36538111 | ||
| Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada | Q36754974 | ||
| Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia | Q37064359 | ||
| Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification | Q37416736 | ||
| Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system | Q37522093 | ||
| Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus | Q38901490 | ||
| Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro | Q39148696 | ||
| Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus | Q39473922 | ||
| Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy | Q39475894 | ||
| Use of an efflux-deficient streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents | Q39610470 | ||
| Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae. | Q39653038 | ||
| The baeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate | Q39679827 | ||
| Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes | Q39730828 | ||
| Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus | Q39740497 | ||
| Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. | Q39845092 | ||
| Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter | Q39864846 | ||
| Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A. | Q40592854 | ||
| Prevention of drug access to bacterial targets: permeability barriers and active efflux | Q40737334 | ||
| Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells | Q40882710 | ||
| Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin | Q42035117 | ||
| Global transcriptome analysis of the responses of a fluoroquinolone-resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin | Q43181777 | ||
| Linezolid resistance in a clinical isolate of Staphylococcus aureus | Q43690311 | ||
| The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus | Q44183691 | ||
| Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus | Q44235729 | ||
| Bacterial resistance modifying agents from Lycopus europaeus | Q44244613 | ||
| A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus | Q44257253 | ||
| Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus | Q44257849 | ||
| Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors | Q44442921 | ||
| Isoflavones as potentiators of antibacterial activity | Q44571372 | ||
| Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus | Q44588035 | ||
| Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria | Q44813822 | ||
| In Pseudomonas aeruginosa ethidium bromide does not induce its own degradation or the assembly of pumps involved in its efflux | Q45107516 | ||
| Identification and biological evaluation of grapefruit oil components as potential novel efflux pump modulators in methicillin-resistant Staphylococcus aureus bacterial strains | Q45124008 | ||
| Antibacterial and resistance modifying activity of Rosmarinus officinalis | Q45160744 | ||
| Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus | Q45219347 | ||
| Remarkable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus | Q46446180 | ||
| Multidrug resistance reversal agent from Jatropha elliptica | Q46624130 | ||
| Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus | Q46662052 | ||
| Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. | Q46713748 | ||
| Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors | Q46734710 | ||
| Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill., Securinega virosa Roxb. &Wlld. and Microglossa pyrifolia Lam. | Q46883325 | ||
| A new chloramphenicol and florfenicol resistance gene flanked by two integron structures in Salmonella typhimurium DT104. | Q47961406 | ||
| Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates | Q47972803 | ||
| Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species. | Q54004587 | ||
| Activity of the tea component epicatechin gallate and analogues against methicillin-resistant Staphylococcus aureus. | Q54031266 | ||
| The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus. | Q54125094 | ||
| Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. | Q54294777 | ||
| In-vitro sensitivity of amoxicillin/clavulanic acid (Augmentin) to isolated beta-lactamases and in-vitro antibacterial activity. | Q54322163 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 1247-1260 | |
| P577 | publication date | 2006-12-04 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Bacterial efflux pump inhibitors from natural sources | |
| P478 | volume | 59 |
| Q39010675 | 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors. |
| Q28547153 | A mass spectrometry-based assay for improved quantitative measurements of efflux pump inhibition |
| Q89907744 | Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance |
| Q41848835 | Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps. |
| Q34187311 | Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. |
| Q93042009 | Alkaloid-Rich Crude Extracts, Fractions and Piperamide Alkaloids of Piper guineense Possess Promising Antibacterial Effects |
| Q57767628 | Alkanna orientalis (L.) Boiss. plant isolated cultures and antimicrobial activity of their extracts: phenomenon, dependence on different factors and effects on some membrane-associated properties of bacteria |
| Q38715925 | An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors. |
| Q36556559 | Antibacterial Effects of Cissus welwitschii and Triumfetta welwitschii Extracts against Escherichia coli and Bacillus cereus |
| Q36556912 | Antibacterial Properties of Alkaloid Extracts from Callistemon citrinus and Vernonia adoensis against Staphylococcus aureus and Pseudomonas aeruginosa |
| Q34469591 | Antibacterial activities of Beilschmiedia obscura and six other Cameroonian medicinal plants against multi-drug resistant Gram-negative phenotypes |
| Q46153850 | Antibacterial activity of some African medicinal plants used traditionally against infectious diseases |
| Q57114947 | Antibacterial and Antibiotic-Potentiating Activities of Thirteen Cameroonian Edible Plants against Gram-Negative Resistant Phenotypes |
| Q64937515 | Antibacterial and Resistance Modifying Activities of Nigella sativa Essential Oil and its Active Compounds Against Listeria monocytogenes. |
| Q35677614 | Antibacterial and antibiotic resistance modifying activity of the extracts from Allanblackia gabonensis, Combretum molle and Gladiolus quartinianus against Gram-negative bacteria including multi-drug resistant phenotypes |
| Q36322582 | Antibacterial and antibiotic resistance modulatory activities of leaves and bark extracts of Recinodindron heudelotii (Euphorbiaceae) against multidrug-resistant Gram-negative bacteria |
| Q42111207 | Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens |
| Q84895718 | Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA) |
| Q37845955 | Antibiotic adjuvants: multicomponent anti-infective strategies. |
| Q27027984 | Antibiotic alternatives: the substitution of antibiotics in animal husbandry? |
| Q92441701 | Antibiotic resistance breakers: current approaches and future directions |
| Q91795762 | Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials |
| Q33869385 | Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria |
| Q28073636 | Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants |
| Q92537808 | Baicalin Inhibits Biofilm Formation and the Quorum-Sensing System by Regulating the MsrA Drug Efflux Pump in Staphylococcus saprophyticus |
| Q34982564 | Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics |
| Q46276454 | Biocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae |
| Q42372809 | Boeravinone B, A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and Intracellular Invasion of Bacteria. |
| Q91833040 | Characterization and evaluation of antimicrobial activity of actinonin against foodborne pathogens |
| Q43290199 | Characterization of functional activity of ABCB1 and ABCC1 proteins in eggs and embryonic cells of the sea urchin Echinometra lucunter. |
| Q24187271 | Chinese herbal medicine for treating recurrent urinary tract infections in women |
| Q24200325 | Chinese herbal medicine for treating recurrent urinary tract infections in women |
| Q92701764 | Chlorophyll and Chlorophyll Derivatives Interfere with Multi-Drug Resistant Cancer Cells and Bacteria |
| Q41774569 | Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein |
| Q33659230 | Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps |
| Q42278779 | Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution? |
| Q35621837 | Development of a novel antimicrobial screening system targeting the pyoverdine-mediated iron acquisition system and xenobiotic efflux pumps. |
| Q40059294 | Development of botanicals to combat antibiotic resistance |
| Q62673364 | Drug combinations: a strategy to extend the life of antibiotics in the 21st century |
| Q44932110 | Drug detoxification dynamics explain the postantibiotic effect |
| Q83492793 | Drug resistance modulation in Staphylococcus aureus, a new biological activity for mesoionic hydrochloride compounds |
| Q41989241 | Effect of galbanic Acid, a sesquiterpene coumarin from ferula szowitsiana, as an inhibitor of efflux mechanism in resistant clinical isolates of Staphylococcus aureus |
| Q92702645 | Effect of α-Bisabolol and Its β-Cyclodextrin Complex as TetK and NorA Efflux Pump Inhibitors in Staphylococcus aureus Strains |
| Q59048791 | Effects of Chlorophyll-Derived Efflux Pump Inhibitor Pheophorbideaand Pyropheophorbideaon Growth and Macrolide Antibiotic Resistance of Indicator and Anaerobic Swine Manure Bacteria |
| Q36366804 | Effects of berberine and hwangryunhaedok-tang on oral bioavailability and pharmacokinetics of ciprofloxacin in rats |
| Q57656351 | Efflux Pumps in Mycobacteria: Antimicrobial Resistance, Physiological Functions, and Role in Pathogenicity |
| Q39021961 | Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors |
| Q64891171 | Efflux pump inhibitors for bacterial pathogens: From bench to bedside. |
| Q38608754 | Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy |
| Q24609407 | Efflux-mediated drug resistance in bacteria: an update |
| Q51461687 | Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli. |
| Q64100555 | Essential Oil, Extracts, and Sesquiterpenes Obtained From the Heartwood of Act as Potential Inhibitors of the NorA Multidrug Efflux Pump |
| Q59112570 | Evaluation of Anti-MRSA and Xanthine Oxidase Inhibition Activities of Phenolic Constituents fromPlumula nelumbinis |
| Q34976536 | Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus |
| Q42839484 | Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis |
| Q89659371 | Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species |
| Q84341110 | Flavonoids from Praxelis clematidea R.M. King and Robinson modulate bacterial drug resistance |
| Q35695747 | Genome sequence and comparative analysis of a putative entomopathogenic Serratia isolated from Caenorhabditis briggsae. |
| Q43128398 | Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. |
| Q28540748 | Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation |
| Q84464779 | In vitro activity of plant extracts and alkaloids against clinical isolates of extended-spectrum β-lactamase (ESBL)-producing strains |
| Q24623997 | In vitro synergistic effect of Psidium guineense (Swartz) in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus strains |
| Q39884320 | Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus |
| Q60961121 | Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance |
| Q40457919 | Inhibition of the multidrug efflux pump LmrS from Staphylococcus aureus by cumin spice Cuminum cyminum. |
| Q40526599 | Inhibitory Effects of Multiple-Dose Treatment with Baicalein on the Pharmacokinetics of Ciprofloxacin in Rats |
| Q44299916 | Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA). |
| Q33812794 | Looking to nature for a new concept in antimicrobial treatments: isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA. |
| Q93083418 | Medicinal chemistry of acridine and its analogues |
| Q36450695 | MexXY multidrug efflux system of Pseudomonas aeruginosa |
| Q33355620 | Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation |
| Q41002233 | Modulation of Drug Resistance in Staphylococcus aureus with Coumarin Derivatives |
| Q40824673 | Modulation of the norfloxacin resistance in Staphylococcus aureus by Cordia verbenaceae DC. |
| Q34299161 | Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors |
| Q35131669 | Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens |
| Q39354491 | Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. |
| Q26741342 | New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms |
| Q39179301 | New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria. |
| Q37324603 | Novel approaches to discovery of antibacterial agents |
| Q37247034 | Pharmacological studies on Buchanania lanzan Spreng.- a focus on wound healing with particular reference to anti-biofilm properties |
| Q64094467 | Phenolic Compounds from as Natural Antimicrobial Products: New Weapons in the Fight against Methicillin Resistant , and Strains |
| Q49232046 | Phytochemical investigation and antimicrobial appraisal of Parrotiopsis jacquemontiana (Decne) Rehder |
| Q42577017 | Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump |
| Q37683439 | Plant antimicrobial agents and their effects on plant and human pathogens |
| Q41382736 | Plant essential oils against Aeromonas hydrophila: in vitro activity and their use in experimentally infected fish |
| Q46631418 | Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis |
| Q34295343 | Plant-derived antimicrobial compounds: alternatives to antibiotics |
| Q99406387 | Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification |
| Q34287501 | Plants as sources of new antimicrobials and resistance-modifying agents |
| Q53805268 | Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae. |
| Q53795718 | Punigratane, a novel pyrrolidine alkaloid from Punica granatum rind with putative efflux inhibition activity. |
| Q39065336 | RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide |
| Q41358824 | Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump. |
| Q40178903 | Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues |
| Q28554197 | Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy |
| Q57809373 | Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection |
| Q37872942 | Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria |
| Q59239164 | Synergistic Effects of n-Hexane Fraction of Parkia biglobosa (Jacq.) Bark Extract and Selected Antibiotics on Bacterial Isolates |
| Q89578706 | Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles |
| Q37323966 | Tackling antibiotic resistance: a dose of common antisense? |
| Q34248092 | Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections |
| Q41676477 | The Biofilm Inhibitor Carolacton Enters Gram-Negative Cells: Studies Using a TolC-Deficient Strain of Escherichia coli |
| Q34044094 | The Essential Oil from Origanum vulgare L. and Its Individual Constituents Carvacrol and Thymol Enhance the Effect of Tetracycline against Staphylococcus aureus |
| Q38852902 | The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention |
| Q37990950 | The antibiotic resistome: challenge and opportunity for therapeutic intervention. |
| Q35482558 | The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria |
| Q41110833 | The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species |
| Q38103861 | The intrinsic resistome of bacterial pathogens |
| Q42836336 | The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis |
| Q54210700 | Tristemma hirtum and Five Other Cameroonian Edible Plants with Weak or No Antibacterial Effects Modulate the Activities of Antibiotics against Gram-Negative Multidrug-Resistant Phenotypes. |
| Q38011247 | Understanding efflux in Gram-negative bacteria: opportunities for drug discovery |
| Q28070164 | Use of Plant Extracts as an Effective Manner to Control Clostridium perfringens Induced Necrotic Enteritis in Poultry |
| Q91943451 | Vanillin mediated green synthesis and application of gold nanoparticles for reversal of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates |
Search more.